Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Emma Marie Bassinder has worked on the following 36 EPO patent applications which have been published in the last five years:

EP11791692

4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS MGLUR 2/3 ANTAGONISTS

IPC classification:
A61K 31/10, C07C 323/58
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11793573

4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS

IPC classification:
A61K 31/21, A61P 25/24, C07C 229/50
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP11813490

BOVINE VIRAL DIARRHEA VIRUS TYPE 1B VACCINE COMPOSITIONS AND METHODS

IPC classification:
A61K 39/12, A61P 31/14
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12704486

METHODS FOR CONTROLLING PAIN IN CANINES USING A TRANSDERMAL SOLUTION OF FENTANYL

IPC classification:
A61K 9/00, A61K 31/4468
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12704489

METHODS FOR CONTROLLING PAIN IN EQUINES USING A TRANSDERMAL SOLUTION OF FENTANYL

IPC classification:
A61K 9/00, A61K 31/4468, A61K 47/10, A61K 47/14
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12726226

SUBSTITUTED INDOLE DERIVATIVES FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS

IPC classification:
A61K 31/496, A61P 37/00, C07D 401/14, C07F 9/141
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12730766

FAST DISSOLVING AZAPERONE GRANULATE FORMULATION

IPC classification:
A61K 9/16, A61K 31/496, A61P 43/00
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP12748299

ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUBLE MONENSIN AND METHODS THEREFOR

IPC classification:
A23K 1/16, A23K 1/17, A23K 1/175, A23K 1/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707629

ISOXAZOLE DERIVATIVES

IPC classification:
A01N 43/80, A01N 47/38, C07D 413/04, C07D 413/14, C07D 417/14, C07D 419/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12721146

PARASITICIDAL DIHYDROISOXAZOLE COMPOUNDS

IPC classification:
A01N 43/80, C07D 413/04, C07D 413/14, C07D 495/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704563

SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL

IPC classification:
B65D 51/28, B65D 81/32
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13706128

METHODS AND COMPOSITIONS FOR REDUCING THE ENVIRONMENTAL IMPACT OF ANIMAL WASTE

IPC classification:
A23K 1/165, A23K 1/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP13721733

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A01N 47/34, A61K 31/17, A61P 33/14
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP11728632

ANTIBIOTIC COMPOSITIONS

IPC classification:
A61K 9/19, A61K 31/7048, A61P 31/04, A61P 33/02
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP13779364

BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK)

IPC classification:
A61K 31/5025, A61P 11/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11745633

LAURIC ACID DISTILLATE FOR ANIMAL FEED

IPC classification:
A23K 1/16, A23K 1/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799490

NEW TREATMENT

IPC classification:
A01N 51/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12704356

MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS

IPC classification:
A61K 31/439, A61K 31/4995, A61P 31/14, C07D 471/18, C07D 471/22, C07D 498/22, C07D 513/18, C07D 515/18
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13814903

AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 33/26, A61P 7/06
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815504

(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES

IPC classification:
A01N 37/18, A01N 43/04, A01N 43/08, A01N 43/10, A01N 43/40
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14712939

1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS

IPC classification:
A01N 43/00, C07F 5/02
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11740921

COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AGAINST CLOSTRIDIUM

IPC classification:
A61K 31/53, A61P 31/04, C07D 487/04
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11788268

METHODS FOR INHIBITING INSECT INFESTATIONS

IPC classification:
A01N 43/22, A01P 7/04, A61K 31/7048
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11764063

FORMULATIONS FOR BOVINE GRANULOCYTE COLONY STIMULATING FACTOR AND VARIANTS THEREOF

IPC classification:
A61K 38/19, A61P 29/00, C07K 14/535
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14733933

PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS

IPC classification:
A61K 31/7048, A61P 33/00, C07H 17/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP15193269

NEW COMBINATION

IPC classification:
A61K 9/20, A61K 31/4184, A61K 31/501, A61K 47/12
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11787778

3-SUBSTITUTED-6-(PYRIDINYLMETHOXY)-PYRROLOPYRIDINE COMPOUNDS

IPC classification:
A61K 31/437, A61P 25/16, C07D 471/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11709952

ENDOPARASITICIDAL COMPOSITIONS

IPC classification:
A01N 37/34, A01N 43/90, A61K 31/277, A61P 33/00
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP12704256

ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS

IPC classification:
A01N 43/84, A01N 47/24
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP11771312

CRYSTALLINE (R)-(E)-2-(4-(2-(5-(1-(3,5-DICHLOROPYRIDIN-4-YL)ETHOXY)-1H-INDAZOL-3-YL)VINYL)-1H-PYRAZOL-1-YL)ETHANOL AND ITS USE AS FGFR INHIBITOR

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/14
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11791146

OXAZOLO[5,4-B]PYRIDIN-5-YL COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/424, A61K 31/437, C07D 413/12, C07D 498/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16188388

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A01N 47/34, A61K 9/50, A61K 31/17, A61P 33/14, A23K 50/80, A23K 20/105
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION PUBLISHED
EP15731204

TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF

IPC classification:
A61K 9/08, A61K 31/48, A61K 47/10, A61K 47/14, A61K 47/16, A61K 47/20, A61K 47/22, A61K 47/40
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15760581

NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS

IPC classification:
A61K 31/18, A61P 33/10, C07C 205/11, C07C 311/08, C07C 311/20, C07D 213/61
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature